Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 407,499 | 407,499 | 0 | 11,569 | 14,381 | 15.73% | +2,812 |
| Kronos Bio, Inc. | 2,765,314 | 2,765,314 | 0 | 3,595 | 3,429 | 3.75% | -166 |
| Allogene Therapeutics, Inc. | 1,798,163 | 1,798,163 | 0 | 8,038 | 4,190 | 4.58% | -3,848 |
| Centessa Pharmaceuticals plc | 3,931,818 | 3,931,818 | 0 | 44,430 | 35,504 | 38.83% | -8,925 |
| Kyverna Therapeutics, Inc.(KYTX) | 4,523,924 | 4,523,924 | 0 | 112,374 | 33,929 | 37.11% | -78,445 |